Study to Assess the Effect of StemAlive® Supplement on the Levels of Stem Cells in Human Volunteers

Assessment of the Effect of StemAlive® Herbal Supplement on the Levels of Circulating Hematopoietic Stem Cells in Human Volunteers

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02027467

Acronym

Hematoalive

Enrollment

Registered

2014-01-06

Start date

2014-02-28

Completion date

2014-04-30

Last updated

2014-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Hematopoietic stem cells, Herbal, Dietary, CD cells, Basic research

Brief summary

Combination of various herbs is known to promote mobilization of hematopoietic stem cells. Hence the current study has been intended to study the effect of Stem Alive® on mobilization of stem cells. Stem Alive® include ingredients like green tea, ashwagandha, etc which are known to be used as traditional medicine. They are also tested qualitatively in academic and nutritional science research centers throughout the world and which substantially according to those studies stimulate the augmented availability of circulating hematopoietic cells. This study is projected to investigate the mobilization of stem cells on healthy human volunteers.

Interventions

DIETARY_SUPPLEMENTStemAlive®

DIETARY_SUPPLEMENTPlacebo (For StemAlive®)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy Male and Female Volunteers * Willing to sign Informed Consent Form

Exclusion criteria

* Anemia * SGOT and Serum Creatinine values twice the upper limit of normal * Volunteers who smoke / consume alcohol / take recreational drugs * Fever or Flu in the last one week of screening * History of Gastric or Duodenal Ulcer * Volunteers on vitamins, nutritional or herbal products since last one month * Pregnant, Breast feeding and Lactating women * Volunteers taking antibiotic, NSAIDS, anti-inflammatory within last 7 days * Allergic to ingredients of test product * Any co morbid or systemic condition or immunocompromised state making volunteer unfit for participation. * Volunteers deemed unfit for the study by the Investigator

Design outcomes

Primary

Measure	Time frame
CD34+	Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14
CD45+	Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14
CD133+	Day 0, Day 1, Day 2, Day 7, Day 12 and Day 14

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026